Advisor Group Holdings, Inc. Marker Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.24 - $4.58 $6,667 - $127,236	27,781 Added 60.12%	73,990 $19,000
Q3 2022 Nov 14, 2022	SELL	$0.3 - $3.73 $600 - $7,460	-2,000 Reduced 4.15%	46,209 $17,000
Q2 2022 Aug 10, 2022	SELL	$0.26 - $0.46 $260 - $460	-1,000 Reduced 2.03%	48,209 $16,000
Q1 2022 May 04, 2022	BUY	$0.37 - $1.0 $1,663 - $4,496	4,496 Added 10.06%	49,209 $22,000
Q3 2021 Nov 05, 2021	SELL	$1.68 - $2.88 $11,592 - $19,872	-6,900 Reduced 13.37%	44,713 $76,000
Q2 2021 Aug 02, 2021	BUY	$1.88 - $3.56 $60,066 - $113,742	31,950 Added 162.49%	51,613 $144,000
Q1 2021 May 13, 2021	BUY	$1.47 - $3.29 $28,904 - $64,691	19,663 New	19,663 $44,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $292M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.